Literature DB >> 11574696

C-SPACE (cleavage-specific amplification of cDNA ends): a novel method of ribozyme-mediated gene identification.

M Krüger1, C Beger, P J Welch, J R Barber, F Wong-Staal.   

Abstract

A hairpin ribozyme, RzCR2A, directed against position 323 of the hepatitis C virus 5'-untranslated region (HCV 5'-UTR) was used to establish and validate a novel method for the detection of cellular target molecules for hairpin ribozymes, termed C-SPACE (cleavage-specific amplification of cDNA ends). For C-SPACE, HeLa mRNA containing the transcript of interest was subjected to in vitro cleavage by RzCR2A in parallel with a control ribozyme, followed by reverse transcription using a modified SMART cDNA amplification method and cleavage-specific PCR analysis. C-SPACE allowed identification of the RzCR2A target transcript from a mixture containing the entire cellular mRNA while only requiring knowledge of the ribozyme binding sequence for amplification. In a similar approach, C-SPACE was used successfully to identify human 20S proteasome alpha-subunit PSMA7 mRNA as the cellular target RNA of Rz3'X, a ribozyme originally designed to cleave the negative strand HCV 3'-UTR. Rz3'X was found to substantially inhibit HCV internal ribosome entry site (IRES) activity and PSMA7 was subsequently confirmed to be involved in HCV IRES-mediated translation. Thereby, C-SPACE was validated as a powerful tool to rapidly identify unknown target RNAs recognized and cleaved by hairpin ribozymes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574696      PMCID: PMC60254          DOI: 10.1093/nar/29.19.e94

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

Review 1.  The potential application of ribozymes for the treatment of hematological disorders.

Authors:  H A James
Journal:  J Leukoc Biol       Date:  1999-09       Impact factor: 4.962

Review 2.  Ribozymes and the anti-gene therapy: how a catalytic RNA can be used to inhibit gene function.

Authors:  A R Muotri; L da Veiga Pereira; L dos Reis Vasques; C F Menck
Journal:  Gene       Date:  1999-09-17       Impact factor: 3.688

3.  The kinetic mechanism of the hairpin ribozyme in vivo: influence of RNA helix stability on intracellular cleavage kinetics.

Authors:  C P Donahue; R S Yadava; S M Nesbitt; M J Fedor
Journal:  J Mol Biol       Date:  2000-01-21       Impact factor: 5.469

4.  A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation.

Authors:  Q X Li; J M Robbins; P J Welch; F Wong-Staal; J R Barber
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

5.  Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells.

Authors:  M Folini; G Colella; R Villa; S Lualdi; M G Daidone; N Zaffaroni
Journal:  J Invest Dermatol       Date:  2000-02       Impact factor: 8.551

6.  Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes.

Authors:  D G Macejak; K L Jensen; S F Jamison; K Domenico; E C Roberts; N Chaudhary; I von Carlowitz; L Bellon; M J Tong; A Conrad; P A Pavco; L M Blatt
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

7.  Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes.

Authors:  P J Welch; E G Marcusson; Q X Li; C Beger; M Krüger; C Zhou; M Leavitt; F Wong-Staal; J R Barber
Journal:  Genomics       Date:  2000-06-15       Impact factor: 5.736

8.  Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.

Authors:  P A Pavco; K S Bouhana; A M Gallegos; A Agrawal; K S Blanchard; S L Grimm; K L Jensen; L E Andrews; F E Wincott; P A Pitot; R J Tressler; C Cushman; M A Reynolds; T J Parry
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

9.  Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells.

Authors:  T Suzuki; B Anderegg; T Ohkawa; A Irie; O Engebraaten; M Halks-Miller; P S Holm; D T Curiel; M Kashani-Sabet; K J Scanlon
Journal:  Gene Ther       Date:  2000-02       Impact factor: 5.250

10.  Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma.

Authors:  T Tsuchida; H Kijima; S Hori; Y Oshika; T Tokunaga; K Kawai; H Yamazaki; Y Ueyama; K J Scanlon; N Tamaoki; M Nakamura
Journal:  Cancer Gene Ther       Date:  2000-03       Impact factor: 5.987

View more
  2 in total

1.  Development and comparison of procedures for the selection of delta ribozyme cleavage sites within the hepatitis B virus.

Authors:  Lucien Junior Bergeron; Jean-Pierre Perreault
Journal:  Nucleic Acids Res       Date:  2002-11-01       Impact factor: 16.971

2.  Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.

Authors:  M Krüger; C Beger; P J Welch; J R Barber; M P Manns; F Wong-Staal
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.